Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...
Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.
Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said ...
Brain scans can provide early warning of who will develop chronic pain following a whiplash injury, a new study finds.
The study was designed to demonstrate PRIMA’s safety and efficacy to reach European market approval (CE mark). PRIMA, owned ...
Roche has released positive topline one-year findings from a Phase IV trial of Vabysmo (faricimab) to treat diabetic macular ...
Alkeus Pharmaceuticals’ study results from Gildeuretinol shows significant trend in slowing geographic atrophy: Cambridge, Massachusetts Friday, October 25, 2024, 10:00 Hrs [IST ...
Up to half of patients showed significant improvement in study results presented at the American Academy of Ophthalmology ...
A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...
MedPage Today on MSN2d
Approval of Bevacizumab Biosimilar Could Eliminate Access to Low-Cost AMD TherapyCHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...
Dr Arshad Khanani anticipates presentations offering new strategies to tackle challenges such as macular atrophy and fibrosis, and optimizing dosing intervals in wet AMD.
REGENXBIO Inc. (Nasdaq: RGNX) today announced positive data from the Phase II fellow eye sub-study evaluating the subretinal delivery of ABBV-RGX-314 in patients with bilateral wet age-related macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback